Table 1.
General characteristics of women according to hormone therapy
|
|
|||
|---|---|---|---|
| No hormone therapy (n=40) | Transdermal estrogens + progesterone (n=30) | Transdermal estrogens + norpregnanes# (n=38) | |
| Age (years) | 59.5 (5.8) | 58.4 (6.1) | 58.7 (5.8) |
| Body-mass index (kg/m2) | 24.3 (3.9) | 23.3 (2.2) | 23.4 (4.1) |
| Waist/Hip ratio | 0.8 (0.1) | 0.8 (0.1) | 0.8 (0.1) |
| Natural menopause | 39 (98) | 30 (100) | 37 (97) |
| Smoking status | |||
| Never users | 24 (60.0) | 12 (40.0) | 22 (58.0) |
| Past users | 11 (28.0) | 12 (40.0) | 13 (34.0) |
| Current users | 5 (12.0) | 6 (20.0) | 3 (8.0) |
| Systolic pressure (mmHg) | 125.7 (20.4) | 120.6 (16.4) | 132.2 (24.2) |
| Diastolic pressure (mmHg) | 74.2 (11.2) | 71.2 (9.3) | 74.6 (12.5) |
| Cholesterol (mg/dl) | 230.1 (30.8) | 223.7 (31.6) | 217.9 (31.3) |
| HDL (mg/dl) | 68.7 (15.4) | 69.7 (15.7) | 71.9 (15.3) |
| Triglyceride (mg/dl) | 80.5 (28.1) | 80.0 (36.9) | 74.7 (39.8) |
| FV Leiden mutation | 2 (5.0) | 1 (3.5) | 2 (5.4) |
| FII 20210 G>A mutation | 2 (5.0) | 0 (0) | 3 (8.1) |
Values are mean (SD) or number (percentages)
*
Women received either nomegestrol acetate (n=23) or promegestone (n=15)